US loss of exclusivity · Oncology

Xgeva

Amgen

2025US biosimilars on sale
2025Today: 20262037
2025 worldwide sales
$2.1B
Date basis
Biosimilars launched
US biosimilars
Copies on the US market
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Xgeva timeline →